Press Release
Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis
Posted on: 16 Apr 18GlobeNewswire
globenewswire.comLast updated on: 16/04/2018